Metraipolis › archive › dc_bcc63f3f117b

Real-World Assessment of Direct Oral Factor Xa Inhibitors: Dosing Appropriateness, Drug Exposure, and Inter-Platform Comparability of Chromogenic Anti-Xa Assays — Europe PMC PMID:42739156

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42739156
DOI
10.3390/diagnostics16172725
License (as archived)
solo-consultazione
Archived
2026-10-08T08:29:18.306Z
SHA-256 of the archived text
e286176de6754d7348def4c79408a2e252e48c45934c1a32ebdcd7c5d284bda2
Stable URL of this page
https://metraipolis.com/documento/dc_bcc63f3f117b

How to cite

Real-World Assessment of Direct Oral Factor Xa Inhibitors: Dosing Appropriateness, Drug Exposure, and Inter-Platform Comparability of Chromogenic Anti-Xa Assays — Europe PMC PMID:42739156 — Europe PMC (en), https://europepmc.org/article/MED/42739156 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcc63f3f117b (Metraipolis archive dc_bcc63f3f117b, sha256 e286176de6754d7348def4c79408a2e252e48c45934c1a32ebdcd7c5d284bda2)
BibTeX
@misc{dcbcc63f3f117b,
  title = {Real-World Assessment of Direct Oral Factor Xa Inhibitors: Dosing Appropriateness, Drug Exposure, and Inter-Platform Comparability of Chromogenic Anti-Xa Assays — Europe PMC PMID:42739156},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42739156},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcc63f3f117b; sha256 e286176de6754d7348def4c79408a2e252e48c45934c1a32ebdcd7c5d284bda2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42739156. Agents can read the archived copy with the MCP tool read_document.